LungenClinic Grosshansdorf

What LungenClinic Grosshansdorf does

LungenClinic Grosshansdorf is a specialty hospital for lung and respiratory diseases located in Großhansdorf, Schleswig-Holstein, Germany, founded in 1900 and owned by Deutsche Rentenversicherung Nord (a German pension insurance institution). It is the first and only G-BA certified Lungenzentrum in Germany, functioning as a designated competence and coordination center for lung disease care in North Germany. The clinic operates approximately 211 beds across five core departments: Pneumology, Thoracic Oncology, Thoracic Surgery, Palliative Medicine, and Anesthesia, supplemented by certified centers including a DKG Lung Cancer Center with Mesothelioma Unit, a DGP Weaning Center, and a DGT Excellence Center for Thoracic Surgery. It serves approximately 12,000 patients annually, performs over 1,100 lung operations per year, and handles roughly 25-30% of all lung cancer patients in Schleswig-Holstein.

The clinic's technology stack includes a Patient Data Management System (PDMS) and a comprehensive patient portal implemented under the German Krankenhauszukunftsgesetz (KHZG) using EU digitalization funds, alongside telemonitoring capabilities via the TELEMENTOR COPD study using Garmin smartwatches. Research infrastructure includes membership in the Deutsches Zentrum für Lungenforschung (DZL) Airway Research Center North, enabling approximately 50 clinical studies and 15 research projects annually, including the HANSE lung cancer screening study with PLCOm2012 risk modeling published in The Lancet Oncology. A new hospital building was commissioned on March 1, 2026, funded by an EUR 80.4 million state grant from Schleswig-Holstein.

Revenue is generated primarily through the German DRG-based reimbursement system under statutory (GKV) and private (PKV) health insurance frameworks, supplemented by EU/KHZG digitalization grants and research funding. The clinic receives patients via referring physicians (Zuweisende), hospital transfers, and direct admission, serving a regional catchment area of Schleswig-Holstein and Hamburg. Academic affiliations with Universität zu Lübeck and Christian-Albrechts-Universität zu Kiel, combined with ERS Training Centre certification, position the clinic as a teaching and research hub for respiratory medicine in North Germany.

Name

LungenClinic Grosshansdorf

Legal name

LungenClinic Grosshansdorf GmbH

Website

https://lungenclinic.de

Company type

Private

Founded year

1900

Operating status

Operating

Headcount range

11–50 employees

Short description

LungenClinic Grosshansdorf is a government-owned specialty hospital in Schleswig-Holstein, Germany, and the first G-BA certified Lungenzentrum in the country. It treats approximately 12,000 lung disease patients annually across pneumology, thoracic oncology, surgery, and palliative care, while serving as a regional referral hub and DZL research partner.

Ownership category

akta.pro rank

Product category

Specialty Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Diagnostic Imaging Centers (621512), Offices of Physicians (62111)

SIC

Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Pulmonary Function & Respiratory Diagnostic Centers (PFT/Spirometry) (HLAFAKAJ)

akta.pro secondary industries

Thoracic (Lung) Oncology (HLAKAFAL), Lung Cancer Screening & Pulmonary Nodule Clinic (HLAKANAI), COPD & Chronic Bronchitis Management (HLAKANAE), Bronchoscopy & Interventional Pulmonology (HLAKANAJ), Asthma & Airway Disease Specialty Care (HLAKAAAC), Cardiac & Pulmonary Clinical Home Health (e.g., CHF/COPD) (HSABACAI)

Keywords

• Lung disease treatment
• Respiratory medicine
• Thoracic surgery
• Pneumology services
• Oncology care

Headquarters

HQ city

Großhansdorf

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Statutory Health Insurance (GKV) Reimbursement: As a hospital under German statutory health insurance, the clinic receives reimbursement for inpatient and outpatient treatments covered by the GKV system, governed by DRG (Diagnosis Related Groups) and outpatient care fee schedules under SGB V.
2. Private Health Insurance (PKV) Reimbursement: The clinic also treats privately insured patients, receiving reimbursement according to the GOÄ (Gebührenordnung für Ärzte) fee schedule for private patients.
3. EU/KHZG Digitalization Fördermittel: The clinic receives EU-sourced funding from the Krankenhauszukunftsfonds (KHZF) under the Krankenhauszukunftsgesetz for digitalization projects including PDMS implementation.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

LungenClinic Grosshansdorf is a specialty hospital providing inpatient and outpatient diagnosis, treatment, and surgery for lung and respiratory diseases, including pneumology, thoracic oncology, thoracic surgery, palliative medicine, ventilator weaning, sleep medicine, and early pneumological rehabilitation. It operates certified centers for lung cancer (with a mesothelioma unit), thoracic surgery (Excellence Center), and weaning, and runs clinical research programs including the HANSE low-dose CT lung cancer screening study and the TELEMENTOR COPD telemonitoring study, supported by a Patient Data Management System and a comprehensive patient portal.

Product overview

LungenClinic Grosshansdorf is a specialized lung and respiratory disease hospital offering comprehensive inpatient and outpatient care across five main departments: Pneumology, Thoracic Oncology, Thoracic Surgery, Palliative Medicine, and Anesthesia. The clinic operates certified centers including a Lung Cancer Center with mesothelioma unit, a Weaning Center for ventilator weaning, and an Excellence Center for Thoracic Surgery. Digital services include a Patient Portal and Patient Data Management System (PDMS). Research activities include the HANSE lung cancer screening study using low-dose CT and the TELEMENTOR COPD remote monitoring program. The clinic serves approximately 12,000 patients annually and operates as a Lung Center recognized by the G-BA, with subsidiaries including GVS (Catering), KGS (Cleaning), and MVZ besseratmen.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Lung cancer detected in 19.4% more cases using PLCOm2012 score vs. NELSON criteria in HANSE study (108 vs 85 cases in comparable groups).
• +5 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability7 records

Feature3 records

Partnerships

13 partnerships are on record, tiered minor and core.

• Krankenhaus Reinbek St. Adolf-StiftminorStrategic or Co-development Partner · 11 July 2024Cooperation agreement between LungenClinic and Krankenhaus Reinbek St. Adolf-Stift for collaboration in patient care, sharing of expertise and potentially referral pathways.
• Universitäres Cancer Center Hamburg (UCCH) / UKEcoreStrategic or Co-development Partner · 1 August 2023Joint research on lung cancer with UCCH/UKE, including molecular characterization of tumors, biomarker research, immunotherapy studies, and shared tumor boards. The collaboration enables combined expertise in treating thorax tumors and sharing of patient cases for clinical trials.
• Wolff & MüllerminorImplementation/ SI/ Consulting Partner · 1 July 2022Construction company responsible for the main building construction of the new hospital. Wolff & Müller builds CO2-neutrally using only electricity from renewable energy sources and was awarded the contract for the new hospital building construction.
• Medizinische Hochschule Hannover (MHH)coreStrategic or Co-development Partner · 29 March 2022MHH is a partner in the HANSE lung cancer screening study alongside LungenClinic and UKSH. MHH Professor Jens Vogel-Claussen serves as study leader. MHH and LungenClinic are both DKG-certified lung cancer centers.
• Universitätsklinikum Schleswig-Holstein (UKSH), Campus LübeckcoreStrategic or Co-development Partner · 29 March 2022UKSH Campus Lübeck is a partner in the HANSE study and both UKSH and LungenClinic are DKG-certified lung cancer centers. Dr. Sabine Bohnet serves as co-author on HANSE study. DZL partner institution.
• Deutsches Zentrum für Lungenforschung (DZL)coreStrategic or Co-development Partner · 1 March 2021LungenClinic is a site of the DZL, specifically the Airway Research Center North (ARCN), together with University Lübeck, Christian-Albrechts-Universität Kiel, UKSH, and Forschungszentrum Borstel. The DZL researches eight major lung diseases including COPD, asthma, lung cancer, and pulmonary fibrosis. The partnership enables direct translation of research findings to patient care and provides access to extensive clinical study programs.
• Henke + Partner ArchitektenminorImplementation/ SI/ Consulting Partner · 8 December 2020General planner and architect for the new hospital building awarded through a Europe-wide tender. The Hamburg-based firm has extensive experience in healthcare facility design and is responsible for the overall architectural planning of the new clinic building.
• Potthoff IngenieurgesellschaftminorImplementation/ SI/ Consulting Partner · 8 December 2020Engineering firm responsible for hospital technical systems including heating, ventilation, sanitation and sustainable energy management in the new hospital building.
• mediplanminorImplementation/ SI/ Consulting Partner · 8 December 2020Hamburg-based company providing consulting for medical technology planning in the new hospital building project.
• RostSehleDeuter Projektsteuerungs GmbHminorImplementation/ SI/ Consulting Partner · 8 December 2020External construction project coordinator working alongside the clinic's project management team to steer the new hospital building project.
• Forschungszentrum BorstelcoreStrategic or Co-development Partner · 1 March 2016DZL partner (ARCN) alongside LungenClinic. Together with University Lübeck, CAU Kiel, and UKSH, forms the Universitäres Lungenzentrum Nord (ULZN) for optimal patient care and excellence in lung disease research.
• Universität zu LübeckcoreStrategic or Co-development Partner · 1 January 2016LungenClinic has an academic affiliation with Universität zu Lübeck. Prof. Martin Reck holds the title of außerplanmäßiger Professor at the university. The clinic is an academic teaching hospital (Akademisches Lehrkrankenhaus) of the university.
• Christian-Albrechts-Universität zu KielcoreStrategic or Co-development Partner · 1 January 2016DZL partner (ARCN) alongside LungenClinic. Prof. Klaus F. Rabe holds a professorship for Pneumology at the medical faculty of CAU Kiel.

Scale indicators9 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Lungenklinik Heckeshorn (Helios Klinikum Emil von Behring): Berlin-based lung clinic within the Helios network, providing specialized pulmonology and thoracic surgery. Closest German peer to LungenClinic Grosshansdorf in terms of specialty lung focus, scope of services (oncology, thoracic surgery, pneumology), and academic teaching status.
• Lungenklinik Hemer: Specialized lung clinic in North Rhine-Westphalia offering pneumology, thoracic surgery, oncology, and weaning. Comparable in scale and service mix to LungenClinic Grosshansdorf, providing benchmark for German specialty lung hospital operations outside of university settings.
• Asklepios Fachkliniken München-Gauting: Munich-area specialty clinic for thoracic medicine, recognized for thoracic surgery and pulmonology within the Asklepios group. Direct competitor for complex thoracic surgery and lung cancer cases in Southern Germany, with comparable certification profile.
• Klinik Schillerstraße (Klinikum am Gesundbrunnen Heilbronn / SLK-Kliniken): Klinik Löwenstein is one of Germany's largest specialized lung clinics, providing pneumology, thoracic surgery, and weaning comparable to LungenClinic Grosshansdorf. Strong comparable for benchmarking specialty lung hospital economics and certification standing.
• Lungenklinik Köln-Merheim (Kliniken der Stadt Köln): Cologne-based lung clinic with comparable pneumology and thoracic surgery profile. Direct competitor for lung cancer referrals and benchmark for DKG-certified lung cancer center economics in a large metropolitan market.

Regional players

• Universitätsklinikum Schleswig-Holstein (UKSH): University hospital covering Schleswig-Holstein with two campuses. Direct regional peer and partner (DZL, HANSE study); competes for complex lung cases in the same catchment but offers broader general hospital services.

Broad incumbents

• Helios Kliniken GmbH: Largest private hospital operator in Germany and Europe, with multiple sites including Lungenklinik Heckeshorn. Provides broader context on hospital group economics, but does not specialize in lung medicine the way LungenClinic Grosshansdorf does.
• Asklepios Kliniken GmbH & Co. KGaA: One of Germany's largest private hospital groups, operating facilities including Asklepios Fachkliniken München-Gauting. Comparable as a broad incumbent with specialty lung exposure, but operates across many disciplines rather than specializing in pulmonary medicine.
• Sana Kliniken AG: Major German private hospital group where incoming Commercial Director Carolin Schaller previously worked. Provides comparable context for mid-sized German specialty hospital economics and benchmarking for the commercial leadership team.

Emerging players

• Royal Brompton Hospital (Guy's and St Thomas' NHS Foundation Trust): UK specialist heart and lung hospital within the NHS, internationally recognized for thoracic surgery and respiratory medicine. Comparable at a European specialty-hospital level and benchmark for translational research-to-care models.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/LungenClinicGrosshansdorf
• LinkedInlinkedin.com/company/lungenclinic-grosshansdorf-gmbh
• Instagraminstagram.com/lungenclinic_grosshansdorf/?hl=de

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LungenClinic Grosshansdorf